Occurrence of additional chromosome aberrations in chronic myeloid leukemia patients treated with imatinib mesylate

被引：68

作者：

Schoch, C

Haferlach, T

Kern, W

Schnittger, S

Berger, U

Hehlmann, R

Hiddemann, W

Hochhaus, A

机构：

[1] Univ Munich, Lab Leukemia Diagnost, Dept Internal Med 3, Univ Grosshadem Hosp, D-81377 Munich, Germany

[2] Univ Heidelberg, Klinikum Mannheim, Med Klin 3, Heidelberg, Germany

来源：

LEUKEMIA | 2003年 / 17卷 / 02期

关键词：

D O I：

10.1038/sj.leu.2402813

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：461 / 463

页数：3

共 10 条

[1] Cytogenetics of chronic myeloid leukaemia [J].

Chase, A ;

Huntly, BJP ;

Cross, NCP .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2001, 14 (03) :553-571

[2] Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome. [J].

Druker, BJ ;

Sawyers, CL ;

Kantarjian, H ;

Resta, DJ ;

Reese, SF ;

Ford, JM ;

Capdeville, R ;

Talpaz, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1038-1042

[3] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

[4] Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification [J].

Gorre, ME ;

Mohammed, M ;

Ellwood, K ;

Hsu, N ;

Paquette, R ;

Rao, PN ;

Sawyers, CL .

SCIENCE, 2001, 293 (5531) :876-880

[5]

HILD F, 1991, NEW ENGL J MED, V325, P132

[6]

Hochhaus A, 2001, SCIENCE, V293, P2163

[7]

Johansson B, 1996, LEUKEMIA, V10, P1134

[8] Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. [J].

Kantarjian, H ;

Sawyers, C ;

Hochhaus, A ;

Guilhot, F ;

Schiffer, C ;

Gambacorti-Passerini, C ;

Niederwieser, D ;

Resta, D ;

Capdeville, R ;

Zoellner, U ;

Talpaz, M ;

Druker, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09) :645-652

[9] PROLONGED SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA AFTER CYTOGENETIC RESPONSE TO INTERFERON-ALPHA THERAPY [J].

KANTARJIAN, HM ;

SMITH, TL ;

OBRIEN, S ;

BERAN, M ;

PIERCE, S ;

TALPAZ, M ;

ROBERTSON, L ;

KOLLER, C ;

ESTEY, E ;

KEATING, MJ .

ANNALS OF INTERNAL MEDICINE, 1995, 122 (04) :254-261

[10]

SOKAL JE, 1988, BLOOD, V72, P294

← 1 →